Leidos Holdings, Inc is an information technology services business based in the US. Leidos Holdings shares (LDOS.US) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $104.11 – an increase of 1.19% over the previous week. Leidos Holdings employs 34,000 staff and has a trailing 12-month revenue of around $12 billion.
Since the stock market crash in March caused by coronavirus, Leidos Holdings's share price has had significant negative movement.
Its last market close was $104.11, which is 11.18% down on its pre-crash value of $117.22 and 53.10% up on the lowest point reached during the March crash when the shares fell as low as $68.
If you had bought $1,000 worth of Leidos Holdings shares at the start of February 2020, those shares would have been worth $691.30 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $1,016.11.
|Latest market close||$104.11|
|52-week range||$67.2876 - $120.4899|
|50-day moving average||$101.5444|
|200-day moving average||$93.3024|
|Wall St. target price||$116.92|
|Dividend yield||$1.36 (1.3%)|
|Earnings per share (TTM)||$4.26|
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
|1 week (2021-01-15)||-2.03%|
|1 month (2020-12-23)||0.36%|
|3 months (2020-10-23)||22.37%|
|6 months (2020-07-22)||14.91%|
|1 year (2020-01-22)||2.46%|
|2 years (2019-01-22)||87.08%|
|3 years (2018-01-22)||56.40%|
|5 years (2016-01-22)||91.03%|
Valuing Leidos Holdings stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Leidos Holdings's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Leidos Holdings's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 24x. In other words, Leidos Holdings shares trade at around 24x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Leidos Holdings's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.34. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Leidos Holdings's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Leidos Holdings's EBITDA (earnings before interest, taxes, depreciation and amortisation) is a whopping $1.3 billion (£0.0 million).
The EBITDA is a measure of a Leidos Holdings's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$12 billion|
|Operating margin TTM||8.28%|
|Gross profit TTM||$1.5 billion|
|Return on assets TTM||5.73%|
|Return on equity TTM||17.6%|
|Market capitalisation||$14.8 billion|
TTM: trailing 12 months
There are currently 2.4 million Leidos Holdings shares held short by investors – that's known as Leidos Holdings's "short interest". This figure is 19.5% up from 2.0 million last month.
There are a few different ways that this level of interest in shorting Leidos Holdings shares can be evaluated.
Leidos Holdings's "short interest ratio" (SIR) is the quantity of Leidos Holdings shares currently shorted divided by the average quantity of Leidos Holdings shares traded daily (recently around 861662.77372263). Leidos Holdings's SIR currently stands at 2.74. In other words for every 100,000 Leidos Holdings shares traded daily on the market, roughly 2740 shares are currently held short.
However Leidos Holdings's short interest can also be evaluated against the total number of Leidos Holdings shares, or, against the total number of tradable Leidos Holdings shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Leidos Holdings's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Leidos Holdings shares in existence, roughly 20 shares are currently held short) or 0.0199% of the tradable shares (for every 100,000 tradable Leidos Holdings shares, roughly 20 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Leidos Holdings.
Find out more about how you can short Leidos Holdings stock.
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Leidos Holdings.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Total ESG risk: 18.77
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Leidos Holdings's overall score of 18.77 (as at 01/01/2019) is pretty good – landing it in it in the 22nd percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Leidos Holdings is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Environmental score: 2.71/100
Leidos Holdings's environmental score of 2.71 puts it squarely in the 2nd percentile of companies rated in the same sector. This could suggest that Leidos Holdings is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Social score: 11.75/100
Leidos Holdings's social score of 11.75 puts it squarely in the 2nd percentile of companies rated in the same sector. This could suggest that Leidos Holdings is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Governance score: 7.82/100
Leidos Holdings's governance score puts it squarely in the 2nd percentile of companies rated in the same sector. That could suggest that Leidos Holdings is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Controversy score: 1/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. A high-profile company, Leidos Holdings scored a 1 out of 5 for controversy – the highest score possible, reflecting that Leidos Holdings has managed to keep its nose clean.
|Total ESG score||18.77|
|Total ESG percentile||21.52|
|Environmental score percentile||2|
|Social score percentile||2|
|Governance score percentile||2|
|Level of controversy||1|
Dividend payout ratio: 23.78% of net profits
Recently Leidos Holdings has paid out, on average, around 23.78% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.3% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Leidos Holdings shareholders could enjoy a 1.3% return on their shares, in the form of dividend payments. In Leidos Holdings's case, that would currently equate to about $1.36 per share.
While Leidos Holdings's payout ratio might seem low, this can signify that Leidos Holdings is investing more in its future growth.
Leidos Holdings's most recent dividend payout was on 31 December 2020. The latest dividend was paid out to all shareholders who bought their shares by 14 December 2020 (the "ex-dividend date").
Leidos Holdings's shares were split on a 405:1000 basis on 30 September 2013. So if you had owned 1000 shares the day before before the split, the next day you'd have owned 405 shares. This wouldn't directly have changed the overall worth of your Leidos Holdings shares – just the quantity. However, indirectly, the new 146.9% higher share price could have impacted the market appetite for Leidos Holdings shares which in turn could have impacted Leidos Holdings's share price.
Over the last 12 months, Leidos Holdings's shares have ranged in value from as little as $67.2876 up to $120.4899. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Leidos Holdings's is 1.0845. This would suggest that Leidos Holdings's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Leidos Holdings, Inc. provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. It operates through three segments: Defense Solutions, Civil, and Health. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S. Intelligence Community, Department of Defense, military services, the U.S. Department of Homeland Security, and government agencies of U.S. allies abroad, as well as other federal, civilian, and commercial customers in the national security industry. Its solutions include technology, intelligence systems, command and control platforms, data analytics, logistics, and cybersecurity solutions, as well as intelligence analysis and operations support services to critical missions. The Civil segment provides systems integration services to Air Navigation Service providers, including the Federal Aviation Administration, Transportation Security Administration, and airport operators; and vehicle and cargo inspection system, which enables the scanning of vehicles and cargo that produces an image using a low radiation dose. It also offers information technology (IT) solutions in cloud computing, mobility, application modernization, DevOps, data center, network modernization, asset management, help desk operations, and digital workplace enablement; federal environment and infrastructure; and logistics services. The Health segment offers solutions to federal and commercial customers responsible for health and well-being of people worldwide, including complex systems integration, managed health services, enterprise IT transformation, and life sciences services. Leidos Holdings, Inc. was founded in 1969 and is headquartered in Reston, Virginia.
Learn more about Transportation and Logistics Systems’ recent performance and where you can invest in Transportation and Logistics Systems shares. We also run through some helpful rules of thumb for any investor.
Learn more about Charlie’s Holdings’ recent performance and where you can invest in Charlie’s Holdings shares. We also run through some helpful rules of thumb for any investor.
Learn more about Lemonade’s recent performance and where you can invest in Lemonade shares. We also run through some helpful rules of thumb for any investor.
Learn more about Unity Software’s recent performance and where you can invest in Unity Software shares. We also run through some helpful rules of thumb for any investor
Learn more about FuelCell Energy’s recent performance and where you can invest in FuelCell Energy shares. We also run through some helpful rules of thumb for any investor.
Learn more about CloudCommerce’s recent performance and where you can invest in CloudCommerce shares. We also run through some helpful rules of thumb for any investor
Ever wondered how to buy shares in Zomedica Pharmaceuticals? We explain how and compare a range of providers that can give you access to many brands, including Zomedica Pharmaceuticals.
Ever wondered how to buy shares in YRC Worldwide? We explain how and compare a range of providers that can give you access to many brands, including YRC Worldwide.
Ever wondered how to buy shares in Xeros Technology Group? We explain how and compare a range of providers that can give you access to many brands, including Xeros Technology Group.
Ever wondered how to buy shares in Xpediator? We explain how and compare a range of providers that can give you access to many brands, including Xpediator.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.